Next Article in Journal
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy
Previous Article in Journal
The MicroRNA miR-155 Is Essential in Fibrosis
Previous Article in Special Issue
Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals
Open AccessFeature PaperReview

Multifunctional miR-155 Pathway in Avian Oncogenic Virus-Induced Neoplastic Diseases

1
Avian Oncogenic Viruses, The Pirbright Institute and the UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Ash Road, Guildford, Surrey GU24 0NF, UK
2
Department of Zoology, University of Oxford, 11a Mansfield Road, Oxford OX1 3SZ, United Kingdom.
*
Author to whom correspondence should be addressed.
Non-Coding RNA 2019, 5(1), 24; https://doi.org/10.3390/ncrna5010024
Received: 14 December 2018 / Revised: 2 March 2019 / Accepted: 8 March 2019 / Published: 13 March 2019
(This article belongs to the Special Issue Non-Coding RNAs in Viral Infections)
MicroRNAs (miRNAs) are small noncoding RNAs that fine-tune the responses of the cell by modulating the cell transcriptome and gene expression. MicroRNA 155 (miR-155) is a conserved multifunctional miRNA involved in multiple roles including the modulation of the immune responses. When deregulated, miR-155 can also contribute to cancer as has been demonstrated in several human malignancies such as diffuse large B cell lymphoma, chronic lymphocytic leukemia, as well as in Epstein–Barr virus (EBV)-induced B cell transformation. Avian oncogenic viruses such as Marek’s disease virus (MDV), avian leukosis virus (ALV), and reticuloendotheliosis virus (REV) that account for more than 90% of cancers in avian species, also make use of the miR-155 pathway during oncogenesis. While oncogenic retroviruses, such as ALV, activate miR-155 by insertional activation, acutely transforming retroviruses use transduced oncogenes such as v-rel to upregulate miR-155 expression. MDV on the other hand, encodes a functional miR-155 ortholog mdv1-miR-M4, similar to the miR-155 ortholog kshv-miR-K11 present in Kaposi’s sarcoma-associated herpesvirus (KSHV). We have shown that mdv1-miR-M4 is critical for the induction of MDV-induced lymphomas further demonstrating the oncogenic potential of miR-155 pathway in cancers irrespective of the diverse etiology. In this review, we discuss on our current understanding of miR-155 function in virus-induced lymphomas focusing primarily on avian oncogenic viruses. View Full-Text
Keywords: miR-155; oncogenesis; EBV; KSHV; MDV; ALV; REV miR-155; oncogenesis; EBV; KSHV; MDV; ALV; REV
Show Figures

Figure 1

MDPI and ACS Style

Bondada, M.S.; Yao, Y.; Nair, V. Multifunctional miR-155 Pathway in Avian Oncogenic Virus-Induced Neoplastic Diseases. Non-Coding RNA 2019, 5, 24. https://doi.org/10.3390/ncrna5010024

AMA Style

Bondada MS, Yao Y, Nair V. Multifunctional miR-155 Pathway in Avian Oncogenic Virus-Induced Neoplastic Diseases. Non-Coding RNA. 2019; 5(1):24. https://doi.org/10.3390/ncrna5010024

Chicago/Turabian Style

Bondada, Megha S.; Yao, Yongxiu; Nair, Venugopal. 2019. "Multifunctional miR-155 Pathway in Avian Oncogenic Virus-Induced Neoplastic Diseases" Non-Coding RNA 5, no. 1: 24. https://doi.org/10.3390/ncrna5010024

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop